← Back to Search

Behavioural Intervention

Glasses for Farsightedness

N/A
Waitlist Available
Research Sponsored by Donald O Mutti, OD, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any ethnicity
Age: between 8 and 15 weeks at baseline examination
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial is testing whether infants with very farsightedness can be helped by a partial correction in their glasses and eye focusing training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Central cycloplegic refractive error with retinoscopy
Secondary outcome measures
Accommodative response with PowerRefractor
Peripheral cycloplegic refractive error with SureSight autorefractor

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Hyperopic subjects receiving glassesExperimental Treatment1 Intervention
Randomized +5.00 to +7.00 diopter hyperopic subjects that will receive partial refractive correction and will be instructed to do accommodation exercises on a daily basis.
Group II: Highly hyperopic subjects correctedActive Control1 Intervention
If a subject is found to be greater than +7.00 diopters hyperopic during the screening phase of the study, they will receive glasses correction and be followed during the study period.
Group III: Hyperopic subjects uncorrectedActive Control1 Intervention
Randomized +5.00 to +7.00 diopter hyperopic subjects that will serve as the control to the experimental arm who will receive no correction but be observed for the duration of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glasses
2012
N/A
~320

Find a Location

Who is running the clinical trial?

Donald O Mutti, OD, PhDLead Sponsor
Ann M Morrison, OD, MSStudy ChairOhio State University
Ann M Morrison, OD, PhDStudy ChairOhio State University
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research involve elderly participants?

"This clinical trial is welcoming participants that are between 8 and 15 Weeks old."

Answered by AI

Who is an appropriate candidate for enrolling in this clinical trial?

"To qualify for this study, participants must possess hyperopia and fall between the ages of 8 weeks to 15 weeks. There are currently 30 openings to fill."

Answered by AI

Does this investigation require additional participants at present?

"According to clinicaltrials.gov, recruitment for this research endeavour has been discontinued since November 12th 2021. It was initially posted on April 24th 2019 and is no longer accepting participants; nonetheless, 15 other studies are in the process of gathering test subjects at present."

Answered by AI
~6 spots leftby Mar 2025